Showing 471-480 of 1688 results for "".
Microbiome in Practice: Assessing OTC Options
https://practicaldermatology.com/topics/atopic-dermatitis/microbiome-in-practice-assessing-otc-options/23123/There’s still much to learn, but clinicians already have tools to manipulate the microbiome.Women in Dermatology With Marina I. Peredo, MD
https://practicaldermatology.com/topics/practice-management/women-in-dermatologywith-marina-i-peredo-md/23083/Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-4/23071/The History of the SDPA: Celebrating 25 Years
https://practicaldermatology.com/series/sdpa-corner/the-history-of-the-sdpa-celebrating-25-years/23065/From an original 49 members, the SDPA has grown to include 3,500 dermatology PAs and introduced numerous initiatives to support dermatology.How Do You Compare? Financial Benchmarking Survey Measures Aesthetic Market
https://practicaldermatology.com/topics/practice-management/how-do-you-compare-financial-benchmarking-survey-measures-aesthetic-market/23002/Results of an annual benchmarking survey among medical aesthetic, dermatology, and medispa practices across the US.10 Things Dermatologists Need to Know About Treating Vitiligo Today
https://practicaldermatology.com/topics/pigmentary-disorders/10-things-dermatologists-need-to-know-about-treating-vitiligo-today/22988/New and emerging treatment approaches offer hope for this challenging condition.FAST ASK: Simplifying Challenging Conversations
https://practicaldermatology.com/topics/practice-management/fast-ask-simplifying-challenging-conversations/22982/Protecting Your Most Valuable Asset: Insurance
https://practicaldermatology.com/topics/practice-management/protecting-your-most-valuable-asset-insurance/20817/A refresher on what you need to know about term life, permanent (cash value) life, and disability insurance.Physician Spotlight
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight/20825/Neurotoxins on the Horizon: Bonti and Beyond
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/neurotoxins-on-the-horizon-bonti-and-beyond/20321/Allergan's acquisition of Bonti highlights the burgeoning potential of the injectable neurotoxin market.